Citigroup’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Citigroup’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-586	Closed	-$22K	–	7854
2018 Q1	$22K	Buy	+586	New	+$24.6K	﹤0.01%	6710

Citigroup's ARMO Position: Q2 2018 in Review

Citigroup sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 586 shares — an estimated $22K sold.

Citigroup first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $22K in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

Citigroup reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Citigroup sold 586 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $22K.
Citigroup first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
Citigroup's ARMO BioSciences, Inc. Common Stock position peaked at $22K in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Citigroup's 13F filing for Q2 2018, filed 10 Aug 2018.